Skip to content

Effect of xylooligosaccharide on intestinal flora and diarrhea after cholecystectomy

Effect of xylooligosaccharide on intestinal flora and diarrhea after cholecystectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038896
Enrollment
Unknown
Registered
2020-10-09
Start date
2020-10-20
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing laparoscopic cholecystectomy

Interventions

Sponsors

Wuxi Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-75 years old; BMI:18-26; 2. Patients diagnosed with gallbladder benign diseases such as gallstone, gallbladder polyp or gallbladder adenomyosis; 3. Patients undergoing elective laparoscopic cholecystectomy; 4. ASA I-II patients; 5. The patients who voluntarily participated in this trial and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who changed the operation mode during the operation; 2. Patients with previous digestive system diseases such as jaundice, cholestasis, liver dysfunction, inflammatory bowel disease, irritable bowel syndrome, intestinal obstruction, rectal prolapse or long-term change of stool habits; patients with previous digestive system or abdominal surgery; patients with previous digestive system or abdominal surgery; 3. Patients who have used gastrointestinal motility drugs, antibiotics, probiotics / prebiotics / synbiotics and other drugs that may change the intestinal flora in the past month; 4. Patients with severe cardiovascular and cerebrovascular diseases and organ failure.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;Hypersensitive C-reactive protein;bile acid;Interleukin 6;Alpha tumor necrosis factor;Serum amyloid A;Adiponectin;white blood cells;bilirubin;Bristol fecal trait score;interferon ?;?-glutamyl transpeptidase;

Countries

China

Contacts

Public ContactEnhong Chen

Wuxi Third People's Hospital

enhomchen522009@163.com+86 15861588020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026